Here, even though we show that the miR-940 levels by themselves can distinguish cancer from normal, we still use PSA as a supportive diagnostic variable and suggest that the use of miR-940 with PSA will be more powerful than using PSA alone for the diagnosis of prostate cancer. This evidence concerns the gene KLK3 and prostate carcinoma.